Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Baker Felix
Relationship:   Director, 10% Owner
City:  
State:  
   
Insider Summary:
  
   
Companies Owned :   20    
Direct Shares   927,207    

Indirect Shares

   141,861,898      
Direct Value   $82,119,756    

Indirect Value

   $12,961,771,173      
Total Shares   142,789,105      
Total Value   $13,043,890,929      


Incyte Corp $32,589,847 Seagen Inc $49,182,531 Synageva BioPharma Corp $0 Genomic Health Inc $18,271 Biocryst Pharmaceuticals Inc $312,474 Neurogene $16,634 Incyte Corp $32,589,847 Seagen Inc $49,182,531 Synageva BioPharma Corp $0 Genomic Health Inc $18,271 Biocryst Pharmaceuticals Inc $312,474 Neurogene $16,634
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    36   
    6    

     Stock price went up :
    15   
    6    
     Stock price went down :
    21   
    0    
   
     Gain/Loss Ratio :
   0.0   
   6.0   
     Percentage Gain/Loss :
   -24.3%
 18.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Incyte Corp INCY Director, 10% Owner 2023-09-29 559,963 2023-09-29 33,480,292    Premium*  
            Ardea Biosciences Inc RDEA Director, 10% Owner 2003-10-06 0 2012-02-01 116,454    Premium*  
            Seagen Inc SGEN Director, 10% Owner 2018-02-01 215,015 2018-02-01 44,355,335    Premium*  
            Synageva BioPharma Corp GEVA Director, 10% Owner 2015-06-22 100,503 2015-06-22 9,328,233    Premium*  
            Viropharma Inc VPHM 10% Owner 2005-01-31 0 2011-12-14 303,264    Premium*  
            Aceragen, Inc ACGN Director 0 2017-07-03 145,453    Premium*  
            Tapestry Pharmaceuticals Inc TPPHQ 10% Owner 0 2008-10-15 0    Premium*  
            Genomic Health Inc GHDX Director, 10% Owner 2012-10-01 288 2012-10-01 11,377,485    Premium*  
            Allos Therapeutics Inc ALTH 10% Owner 0 2009-02-06 1,629    Premium*  
            Biocryst Pharmaceuticals Inc BCRX 10% Owner 2016-08-16 46,918 2016-08-16 9,418,390    Premium*  
            Heron Therapeutics Inc HRTX 10% Owner 0 2011-06-30 5,266,568    Premium*  
            Adolor Corp ADLR 10% Owner 2010-04-26 0 2011-12-19 0    Premium*  
            Diadexus Inc DDXS 10% Owner 0 2010-07-28 140,525    Premium*  
            Pharmacyclics Inc PCYC 10% Owner 0 2011-08-22 1,809    Premium*  
            Ocera Therapeutics Inc OCRX 10% Owner 2012-03-12 0 2012-03-14 57,704    Premium*  
            XOMA Corporation XOMA Director, 10% Owner 2012-10-29 0 2012-10-29 480,639    Premium*  
            Neurogene NGNE 10% Owner 2015-08-07 4,520 0    Premium*  
            Invitae Corp NVTA 10% Owner 0 2015-08-27 6,554,967    Premium*  
            Bellicum Pharmaceuticals, Inc BLCM 10% Owner 0 2015-12-24 4,865,647    Premium*  
            Kodiak Sciences Inc. KOD Director, 10% Owner 2022-01-21 0 2022-06-06 15,967,504    Premium*  
* Premium Members only  

Records found :    1397         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 14 of 56
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
GHDX Genomic Health Inc Director   –       •       •   2009-05-07 4 B $19.53 $30,638 I/I 1,568 95,893 2.25 -
VPHM Viropharma Inc 10% Owner   –       –       •   2007-04-17 4 S $15.43 $53,677 I/I (3,477) 96,045 0 -
ACGN Aceragen, Inc 10% Owner   –       –       •   2007-12-06 4 S $12.35 $29,833 I/I (2,415) 96,341 0 -
GHDX Genomic Health Inc Director   –       •       •   2009-05-08 4 B $19.67 $16,110 I/I 819 96,712 2.17 -
ALTH Allos Therapeutics Inc 10% Owner   –       –       •   2008-01-14 4 B $7.41 $13,873 I/I 1,871 96,941 1.5 -
ALTH Allos Therapeutics Inc 10% Owner   –       –       •   2008-01-15 4 B $7.50 $2,993 I/I 399 97,340 1.42 -
ALTH Allos Therapeutics Inc 10% Owner   –       –       •   2008-01-18 4 B $7.15 $1,365 I/I 190 97,530 1.42 -
ALTH Allos Therapeutics Inc 10% Owner   –       –       •   2008-01-22 4 B $6.92 $76 I/I 11 97,541 1.42 -
ALTH Allos Therapeutics Inc 10% Owner   –       –       •   2008-01-23 4 B $6.95 $2,725 I/I 392 97,933 1.42 -
GHDX Genomic Health Inc Director   –       •       •   2009-05-11 4 B $19.36 $28,051 I/I 1,440 98,152 2.25 -
ALTH Allos Therapeutics Inc 10% Owner   –       –       •   2008-02-19 4 B $6.75 $3,039 I/I 450 98,383 1.42 -
ACGN Aceragen, Inc 10% Owner   –       –       •   2007-12-05 4 S $12.28 $14,544 I/I (1,184) 98,756 0 -
ALTH Allos Therapeutics Inc 10% Owner   –       –       •   2008-02-20 4 B $6.50 $2,944 I/I 453 98,836 1.42 -
GHDX Genomic Health Inc Director   –       •       •   2009-05-20 4 B $17.88 $17,698 I/I 984 99,136 2.17 -
ALTH Allos Therapeutics Inc 10% Owner   –       –       •   2007-01-29 4 B $6.00 $263,724 I/I 43,954 99,249 1.5 -
GHDX Genomic Health Inc Director   –       •       •   2009-05-21 4 B $17.82 $2,210 I/I 124 99,260 2.17 -
ALTH Allos Therapeutics Inc 10% Owner   –       –       •   2008-02-21 4 B $5.90 $3,730 I/I 617 99,453 1.42 -
VPHM Viropharma Inc 10% Owner   –       –       •   2007-04-16 4 S $15.44 $25,793 I/I (1,667) 99,522 0 -
RDEA Ardea Biosciences Inc 10% Owner   –       –       •   2008-12-19 4/A B $11.14 $44,449 I/I 3,990 99,636 1.5 -
ALTH Allos Therapeutics Inc 10% Owner   –       –       •   2008-02-25 4 B $6.00 $2,550 I/I 425 99,878 1.42 -
GEVA Synageva BioPharma Corp Director   –       •       •   2015-06-22 4 A $0.00 $0 D/D 99,503 100,003 0 -
VPHM Viropharma Inc 10% Owner   –       –       •   2007-04-13 4 S $15.30 $147,728 I/I (9,650) 101,189 0 -
RDEA Ardea Biosciences Inc 10% Owner   –       –       •   2006-02-24 4 B $3.35 $9,601 I/I 2,866 101,342 1.5 -
VPHM Viropharma Inc 10% Owner   –       –       •   2006-02-28 4 S $19.90 $315,218 I/I (15,707) 103,540 -
INCY Incyte Corp Director   –       •       •   2008-01-04 4 B $9.47 $89,857 I/I 9,492 104,453 2.25 -
  1397  Records found
  1   2   3   4   5   6   7   8   9   10   11   12   13   14  15   16   17   18   19   20   21   22   23   24   25   26   27   28   29   30   31   32   33   34   35   36   37   38   39   40   41   42   43   44   45   46   47   48   49   50   51   52   53   54   55   56      
  Page 14 of 56  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us